Andrew Callos
Corporate Officer/Principal chez CYTOKINETICS, INCORPORATED
Fortune : 4 M $ au 30/04/2024
Profil
Mr. Andrew Callos is a Chief Commercial Officer & Executive VP at Cytokinetics, Inc. Mr. Callos was previously employed as a Vice President-US Cardiology & Metabolic Marketing by Pfizer Inc. and an Assistant Vice President-Marketing by Wyeth Pharmaceuticals, Inc. He received his undergraduate degree from Drexel University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/03/2024 | 63 887 ( 0,06% ) | 4 M $ | 30/04/2024 |
Postes actifs de Andrew Callos
| Sociétés | Poste | Début |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/03/2021 |
Anciens postes connus de Andrew Callos
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Sales & Marketing | - |
Formation de Andrew Callos
| Drexel University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
